New York Life Investment Management’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-121,233
Closed -$6.29M 1322
2024
Q1
$6.29M Buy
121,233
+29,431
+32% +$1.69M 0.06% 275
2023
Q4
$5.7M Buy
91,802
+19,707
+27% +$1.59M 0.06% 292
2023
Q3
$6.72M Buy
72,095
+6,852
+11% +$644K 0.07% 249
2023
Q2
$6.52M Buy
+65,243
New +$9.2M 0.07% 264
2023
Q1
Sell
-1,334
Closed -$301K 1406
2022
Q4
$301K Buy
1,334
+444
+50% +$122K ﹤0.01% 1122
2022
Q3
$302K Sell
890
-10
-1% -$3.31K ﹤0.01% 1104
2022
Q2
$332K Buy
+900
New +$355K ﹤0.01% 1117

Other funds holding VXX

New York Life Investment Management's VXX Position: Q2 2024 in Review

New York Life Investment Management sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2024, closing a stake of 121,233 shares — an estimated $6.29M sold.

New York Life Investment Management first reported a position in VXX in Q2 2022 and held it in 7 quarters. The position peaked at $6.72M in Q3 2023. 68 funds tracked by Wall St. Rank hold VXX as of Q2 2024.

  • New York Life Investment Management reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 121,233 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2024, an estimated $6.29M.
  • New York Life Investment Management first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2022 and held it in 7 quarters.
  • New York Life Investment Management's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $6.72M in Q3 2023.
  • 68 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.